Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AMGN save search
AMGN Investors Have Opportunity to Lead Amgen Inc. Securities Fraud Lawsuit
Published: 2023-03-24 (Crawled : 01:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.48%
H: 1.83%
C: 1.63%
ALCO | $27.99 4.21% 4.04% 22K
|
Process Industries
|
| O: -0.37%
H: 0.82%
C: 0.46%
ALCO Investors Have Opportunity to Lead Alico, Inc. Securities Fraud Lawsuit
Published: 2023-03-24 (Crawled : 01:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.48%
H: 1.83%
C: 1.63%
ALCO | $27.99 4.21% 4.04% 22K
|
Process Industries
|
| O: -0.37%
H: 0.82%
C: 0.46%
AMGN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 12, 2023 in the Class Action Filed on Behalf of Amgen Inc. Shareholders
Published: 2023-03-21 (Crawled : 10:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.0%
H: 0.24%
C: -0.75%
deadline
Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Match Group, Inc. (MTCH) that a Securities Fraud Class Action Lawsuit Has Been Filed On Their Behalf
Published: 2023-03-19 (Crawled : 00:00) - prnewswire.com
CSGKF | $0.89 4.69% 51K
|
Finance
|
| O: -53.7%
H: 10.83%
C: -2.63%
CS | $0.8858 1.49% 64M
|
Finance
|
| O: -55.64%
H: 0.0%
C: 0.0%
MTCH | $32.17 -0.16% -0.16% 4M
|
Technology Services
|
| O: 0.6%
H: 1.81%
C: 0.81%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.34%
H: 1.99%
C: 1.8%
CREDIT SUISSE CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Credit Suisse Group AG
Published: 2023-03-18 (Crawled : 16:20) - prnewswire.com
CGNT | $6.445 -1.45% -1.47% 420K
|
| Email alert
Add to watchlist
CS | $0.8858 1.49% 64M
|
Finance
| Email alert
Add to watchlist
CSGKF | $0.89 4.69% 51K
|
Finance
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
group
CS EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Expands Class Period to Include More Investors of Credit Suisse Group AG Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CS
Published: 2023-03-16 (Crawled : 22:00) - prnewswire.com
CSGKF | $0.89 4.69% 51K
|
Finance
|
| O: -5.16%
H: 0.0%
C: -5.45%
CS | $0.8858 1.49% 64M
|
Finance
|
| O: -5.56%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.43%
H: 0.1%
C: -1.62%
deadline group
ROSEN, A LEADING NATIONAL FIRM, Encourages Caribou Biosciences, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CRBU
Published: 2023-03-16 (Crawled : 22:00) - prnewswire.com
CSGKF | $0.89 4.69% 51K
|
Finance
|
| O: -5.16%
H: 0.0%
C: -5.45%
CRBU | $3.87 -1.02% -1.03% 1.7M
|
Health Technology
|
| O: -1.19%
H: 1.41%
C: -0.4%
CS | $0.8858 1.49% 64M
|
Finance
|
| O: -5.56%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.43%
H: 0.1%
C: -1.62%
deadline
FIRST REPUBLIC BANK (NYSE: FRC) INVESTIGATION ALERT: Bernstein Liebhard is investigating possible securities claims against First Republic Bank
Published: 2023-03-16 (Crawled : 21:00) - prnewswire.com
PHI | $23.16 1.8% 0.0% 49K
|
Communications
|
| O: 2.51%
H: 0.63%
C: -1.98%
FRC | $3.51 -45.9% 180M
|
Finance
|
| O: 41.84%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.43%
H: 0.1%
C: -1.62%
AMGN ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Amgen Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AMGN
Published: 2023-03-16 (Crawled : 20:00) - prnewswire.com
WAL M | $57.44 3.05% 0.0% 4M
|
Finance
|
| O: -6.04%
H: 2.02%
C: -9.69%
PACW | $7.54 0.27% 25M
|
Finance
|
| O: -12.66%
H: 6.7%
C: -7.2%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.43%
H: 0.1%
C: -1.62%
trusted deadline
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027; The increase in special drug designations to drive growth- Technavio
Published: 2023-03-16 (Crawled : 02:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.16%
H: 0.73%
C: 0.73%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 0.44%
H: 0.29%
C: 0.29%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.18%
H: 0.77%
C: 0.64%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -4.62%
H: 4.44%
C: -6.05%
GBIO | $2.81 1.08% 1.07% 250K
|
Health Technology
|
| O: -0.55%
H: 6.69%
C: 1.95%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -1.11%
H: 2.97%
C: 2.23%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.49%
H: 0.39%
C: 0.36%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: -2.65%
H: 14.55%
C: 9.09%
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -2.29%
H: 3.52%
C: -0.78%
drug therapy market
The Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market is forecast to grow by $ 2061.88 mn during 2022-2027, accelerating at a CAGR of 7.96% during the forecast period
Published: 2023-03-15 (Crawled : 15:20) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.62%
H: 0.0%
C: -3.57%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.0%
H: 1.39%
C: 1.02%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.95%
H: 1.05%
C: 0.54%
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -0.81%
H: 3.48%
C: -0.82%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -1.09%
H: 1.45%
C: 1.24%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: 0.67%
H: 0.67%
C: -2.22%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.08%
H: 2.24%
C: 1.95%
global therapeutics market
Bronstein, Gewirtz & Grossman, LLC Notifies Amgen Inc. (AMGN) Investors of Class Action and to Actively Participate
Published: 2023-03-14 (Crawled : 22:00) - prnewswire.com
CSGKF | $0.89 4.69% 51K
|
Finance
|
| O: -29.46%
H: 26.47%
C: 21.76%
CS | $0.8858 1.49% 64M
|
Finance
|
| O: -30.71%
H: 0.0%
C: 0.0%
DKNG | $40.685 -2.29% -2.35% 12M
|
Technology Services
|
| O: -2.71%
H: 2.39%
C: 2.27%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.08%
H: 2.24%
C: 1.95%
Global Gene Therapy Market to Grow by $4.61 Billion During 2023-2027
Published: 2023-03-14 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 1.01%
H: 0.43%
C: 0.29%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.28%
H: 0.38%
C: 0.31%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.01%
H: 7.6%
C: 7.6%
GBIO | $2.81 1.08% 1.07% 250K
|
Health Technology
|
| O: 3.79%
H: 2.61%
C: -1.57%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 1.4%
H: 1.39%
C: 0.07%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -1.23%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 0.9%
H: 4.46%
C: 2.68%
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: 2.79%
H: 8.53%
C: 0.78%
global therapy market
Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2,061.88 million between 2022 and 2027; Growth driven by increasing approval of therapeutics - Technavio
Published: 2023-03-10 (Crawled : 23:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
CTIC | $9.09 0.05% 11M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
| Email alert
Add to watchlist
approval therapeutics growth market
Global Best Selling Pharmaceutical Drugs Analysis Report 2023: Revenue Forecast of the Top 50 Pharmaceutical Drugs and Assessment of their Regulatory Landscape through 2021
Published: 2023-03-10 (Crawled : 20:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
CSLLY | $86.918 3.3% 60K
|
n/a
| Email alert
Add to watchlist
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
MNKPF | $17.25
|
n/a
| Email alert
Add to watchlist
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
ENDP | $0.2926 -9.6%
|
Health Technology
| Email alert
Add to watchlist
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
| Email alert
Add to watchlist
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
UCBJY | $63.676 -4.38% 7.2K
|
Manufacturing
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
ALPMF | $9.17 43.47% 16K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
| Email alert
Add to watchlist
UCBJF | $126.05 -39.66% 100
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
ENDPQ | $0.0006 -50.0% 3.4K
|
n/a
| Email alert
Add to watchlist
CMXHF | $172.54 -19.21% 50
|
n/a
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
global report
AMGEN TO PRESENT AT THE 33rd ANNUAL OPPENHEIMER HEALTHCARE CONFERENCE
Published: 2023-03-09 (Crawled : 23:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.43%
H: 1.55%
C: 0.49%
conference
AMGEN ANNOUNCES 2023 SECOND QUARTER DIVIDEND
Published: 2023-03-07 (Crawled : 00:00) - biospace.com/
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: -0.57%
H: 1.01%
C: -2.44%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.0%
H: 0.04%
C: -2.72%
Type 2 diabetes market size to increase by USD 39.37 billion between 2022 and 2027; Growth driven by increasing prevalence of diabetes - Technavio
Published: 2023-03-03 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.09%
H: 1.57%
C: 1.51%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.0%
H: 0.73%
C: -0.19%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: -0.1%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.55%
H: 0.27%
C: 0.04%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.38%
H: 0.65%
C: 0.61%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 1.11%
H: 0.67%
C: -0.3%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.61%
H: 0.8%
C: 0.77%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.11%
H: 0.38%
C: -0.08%
diabetes growth market
Zai Lab Announces Full-Year 2022 Financial Results and Recent Corporate Updates
Published: 2023-03-01 (Crawled : 22:00) - globenewswire.com
ZLAB | News | $14.08 -0.99% -0.99% 470K
|
Health Technology
|
| O: -9.19%
H: 6.71%
C: 0.71%
DCPH | $14.69 3.23% 3.13% 390K
|
Health Technology
|
| O: -1.15%
H: 0.82%
C: -0.62%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.03%
H: 0.11%
C: -0.58%
financial results
AMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC
Published: 2023-03-01 (Crawled : 16:00) - biospace.com/
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 4.08%
H: 3.06%
C: 0.89%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.56%
H: 2.63%
C: 2.53%
repatha
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
UONE | $2.36 19.8% 16.53% 75K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.